F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis

Clinical Nuclear Medicine

Volumn 29, Issue 7, 2004, Pages 452-453

  Hsu, Chung Huei ^a   Lee, Chi Ming ^a   Chia, Chee Fah ^a   Lin, Yun Ho ^a  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Actinomycosis; FDG PET; Fistula

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACTINOMYCOSIS; ADULT; ANUS FISTULA; ARTICLE; BUTTOCK; CANCER SCINTISCANNING; CANCER SCREENING; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; HUMAN; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; RECTUM CANCER; RECTUM FISTULA; SYMPTOM; WHOLE BODY SCINTISCANNING;

ACTINOMYCOSIS; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RECTAL FISTULA; RECTAL NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2942666277     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000129132.94660.4a     Document Type: Article

References (14)

1. Miettinen M, El-Rifai W, Sobin L, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002;33:478.
2. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002; 5(suppl):39.
3. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer. 2002;5(suppl):60.
4. Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696.
5. Sabir N, Sungurtekin U, Erdem E, et al. Magnetic resonance imaging with rectal GD-DTPA: new tool for the diagnosis of perianal fistula. Int J Colorectal Dis. 2002;15:317.
6. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology. 2001;121:1064.
7. Gould SW, Martin S, Agarwal T, et al. Image-guided surgery for anal fistula in a 0. 5T interventional MRI unit. J Magn Reson Imaging. 2002;16:267.
8. Cintron JR, Del Pino A, Duarte B, et al. Abdominal actinomycosis. Dis Colon Rectum. 1996;39:105.
9. Shimada M, Kotani T, Ohtaki S, et al. Primary perianal actinomycosis over a thirty year period. Jpn J Surg. 1986;16:302.
10. Alvarado-Cema R, Bracho-Riquelme R. Perianal actinomycosis-a complication of a fistula-in-ano. Report of a case. Dis Colon Rectum. 1994;37:378.
11. Fry RD, Birnbaum EH, Lacey DL. Actinomyces as a cause of recurrent perianal fistula in the immunocompromised patient. Surgery. 1992;111: 591.
12. Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med. 1998;25:1238.
13. Park CH, Lee MH, Oh CG. F-18 FDG positron emission tomographic imaging in bilateral iliopsoas abscesses. Clin Nucl Med. 2002;27:680.
14. Tsuyuguchi N, Sunada I, Ohata K, et al. Evaluation or treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med. 2003;17:47.